AntineoplasticsLiver function damage and hand-foot syndrome: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1927卷 / 1期

关键词：

D O I：

10.1007/s40278-022-24805-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：69 / 69

相关论文

共 50 条

[1] RegorafenibAnorexia and hand-foot syndrome: 2 case reports
Reactions Weekly, 2019, 1782 (1) : 276 - 276
[2] RivoceranibHypertension and hand-foot syndrome: 2 case reports
Reactions Weekly, 2023, 1979 (1) : 420 - 420
[3] CatequentinibOral ulcer and hand-foot syndrome: 2 case reports
Reactions Weekly, 2020, 1832 (1) : 92 - 92
[4] Capecitabine/pyrotinibDiarrhoea and Hand-foot syndrome: 2 case reports
Reactions Weekly, 2025, 2051 (1) : 77 - 77
[5] Three case reports of Hand-Foot Syndrome with gefitinib
Razis, Evangelia
Karina, Maria
Karanastassi, Sofia
Fountzilas, George
CANCER INVESTIGATION, 2006, 24 (05) : 514 - 516
[6] CatequentinibOral pain and hand-foot skin syndrome:2 case reports
Reactions Weekly, 2022, 1935 (1) : 132 - 132
[7] SunitinibHypertension, asthenia and hand-foot syndrome: 3 case reports
Reactions Weekly, 2015, 1572 (1) : 189 - 189
[8] SorafenibHypertension, diarrhoea and hand-foot syndrome: 4 case reports
Reactions Weekly, 2015, 1574 (1) : 227 - 227
[9] LenvatinibHypertension, hand-foot syndrome and fatigue: 3 case reports
Reactions Weekly, 2023, 1953 (1) : 234 - 234
[10] RivoceranibHypertension, proteinuria and hand-foot syndrome: 3 case reports
Reactions Weekly, 2019, 1767 (1) : 273 - 273

← 1 2 3 4 5 →